Advocacy Group Pressures FDA Nominee Over Mail-Order Abortion Drug Policy
The latest in this situation
How it started
What happened
Fifty pro-life leaders released a letter urging the U.S. Food and Drug Administration (FDA) to take action regarding the mail-order abortion drug scheme. The call was directed at Dr. Heidi Overton, the nominee for FDA Commissioner. The leaders, including Tony Perkins of the Family Research Council, called on the FDA to revoke the mail-order scheme, arguing it was undermining the *Dobbs* decision.
From breitbart.com
Why it matters
The pressure campaign focuses on the FDA's policy regarding mifepristone, which has been available through a mail-order scheme. This scheme allows abortion drugs to be mailed into states with different laws. The leaders argue that the current policy allows for the continued of the mail-order scheme despite the challenges to the Biden administration's original permissive policy.
From breitbart.com
Who's involved
- FDAThe U.S. Food and Drug Administration, the agency whose policy is under scrutiny.
- Heidi OvertonThe nominee for FDA Commissioner, facing calls to reverse the agency's permissive policy.
- Tony PerkinsPresident of the Family Research Council, leading the advocacy push.
- Family Research CouncilThe organization of the leaders who issued the letter demanding policy change.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- FDASpeculative
The FDA might face political pressure to revoke its mail-order scheme regarding mifepristone.
How it developed
Newest first. Tap a step to see who reported it.- Fox News reports on agency actions and challenges as the FDA nominee faces confirmation hearing pressure.Sub-event
Supreme Court ruling influences FDA policy while Heidi Overton is nominated to lead the agency.1 source
Keep exploring
The entities involved
- FDA
-
Heidi Overton
American policy advisor
Nothing else this week.
-
Tony Perkins
Christian political figure in the United States
Related events
- Medical societies and AAP challenge FDA guidance on e-cigarettes, while Congress grants FDA authority to regulate tobacco.
- Litigation regarding FDA approval process.
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
- OMB reviews a proposed FDA peptide rule while former chiefs criticize RIF efforts and Overton pushes vaccine reduction changes.
- Expertise is guiding drug development toward regulatory approval, involving the FDA and David Rubenstein.